Advertisement

Topics

FDA user fee reauthorization bill passes US House of Representatives

05:04 EDT 11 Aug 2017 | Generics and Biosimilars Initiative

The US House of Representatives passed a bill on 12 July 2017 reauthorizing the US Food and Drug Administration’s (FDA) prescription drug, generic drug, biosimilar and medical device user fee programmes.

Original Article: FDA user fee reauthorization bill passes US House of Representatives

NEXT ARTICLE

More From BioPortfolio on "FDA user fee reauthorization bill passes US House of Representatives"

Quick Search
Advertisement
 

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Prescription Drugs
A prescription drug (also prescription medication or prescription medicine) is a licensed medicine that is regulated by legislation to require a medical prescription before it can be obtained. The term is used to distinguish it from over-the-counter drug...